Intervention

Lenalidomide

ClinicalTrials.gov intervention label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 18 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting1
Common conditions25
Lead sponsors shown14
Advertisement

Clinical trials

18 shown
Prevention of Anthracycline-Induced Cardiac Dysfunction With Dexrazoxane in Patients With Diffuse Large-B Cell LymphomaNCT06220032 · 2024-08-15
RECRUITING
Combining Latency Reversing Agents to Address the HIV ReservoirNCT07384624 · 2026-04-01
NOT_YET_RECRUITING
Immunomodulators on HIV-1 ReservoirNCT05598580 · 2022-11-20
UNKNOWN
Phase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung CancerNCT02963610 · 2017-03-29
TERMINATED
Lenalidomide for Adult Histiocyte DisordersNCT02523040 · 2015-08-01
ACTIVE_NOT_RECRUITING
Lenalidomide Maintenance Therapy in Stage IIIB/IV Non-small Cell Lung CancerNCT02018523 · 2014-06-01
TERMINATED
Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)NCT01704781 · 2012-09-01
COMPLETED
Revlimid® as Consolidation Treatment Chronic Lymphocytic LeukemiaNCT01600053 · 2011-11-01
TERMINATED
Lenalidomide in Kaposi Disease Associated With HIV InfectionNCT01282047 · 2011-10-01
TERMINATED
Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsNCT01352962 · 2011-09-26
COMPLETED
Lenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaNCT01057121 · 2010-08-27
COMPLETED
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)NCT01183663 · 2010-08-01
COMPLETED
Lenalidomide and Cetuximab in Patients With Advanced Solid TumorsNCT01166035 · 2010-03-01
UNKNOWN
Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate CancerNCT00988208 · 2009-11-11
COMPLETED
Lenalidomide and Paclitaxel in Prostate CancerNCT00933426 · 2009-08-01
TERMINATED
A Phase 2 Trial of Bevacizumab, Lenalidomide, Docetaxel, and Prednisone (ART-P) for Treatment of Metastatic Castrate-Resistant Prostate CancerNCT00942578 · 2009-07-16
COMPLETED
A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing FatigueNCT00792077 · 2008-11-01
COMPLETED
Study of Lenalidomide and Docetaxel in Subjects With Androgen Independent Prostate CancerNCT01378091 · 2005-08-01
COMPLETED

Common conditions

Prostate Cancer3Advanced Cancers1AIDS-Related Kaposi Sarcoma1Cancer of the Urethra1Carcinoma, Non-Small-Cell Lung1Chronic Lymphocytic Leukemia1CLL1DLBCL - Diffuse Large B Cell Lymphoma1Histiocytic Sarcoma (HS)1Histiocytoses Erdheim-chester Disease1HIV -1 Infection1HIV (Human Immunodeficiency Virus)1HIV Infection Associated Kaposi Disease1HIV Infections1HIV-1 Infection1Langerhans Cell Histiocytosis (LCH)1Leukemia1Metastatic Prostate Cancer1Neoplasms, Urethral1Nonsmall Cell Lung Cancer1Recurrent Kaposi Sarcoma1Relapsed or Refractory Solid Tumors1Solid Tumors1Urethral Cancer1Urethral Neoplasms1

Trial status mix

COMPLETED8
TERMINATED5
UNKNOWN2
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1
RECRUITING1

Phase mix

PHASE110
PHASE210
PHASE32
PHASE41
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.